Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $868.91 million. The enterprise value is $65.55 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
RCUS has 105.84 million shares outstanding. The number of shares has increased by 21.76% in one year.
Current Share Class | 105.84M |
Shares Outstanding | 105.84M |
Shares Change (YoY) | +21.76% |
Shares Change (QoQ) | +0.33% |
Owned by Insiders (%) | 4.12% |
Owned by Institutions (%) | 51.30% |
Float | 65.84M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.96 |
Forward PS | 6.19 |
PB Ratio | 1.61 |
P/TBV Ratio | 1.85 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.50, with a Debt / Equity ratio of 0.33.
Current Ratio | 4.50 |
Quick Ratio | 4.44 |
Debt / Equity | 0.33 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -77.50 |
Financial Efficiency
Return on equity (ROE) is -59.77% and return on invested capital (ROIC) is -31.58%.
Return on Equity (ROE) | -59.77% |
Return on Assets (ROA) | -17.26% |
Return on Invested Capital (ROIC) | -31.58% |
Return on Capital Employed (ROCE) | -33.55% |
Revenue Per Employee | $411,483 |
Profits Per Employee | -$451,356 |
Employee Count | 627 |
Asset Turnover | 0.23 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $1.00 million in taxes.
Income Tax | 1.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.53% in the last 52 weeks. The beta is 1.36, so RCUS's price volatility has been higher than the market average.
Beta (5Y) | 1.36 |
52-Week Price Change | -54.53% |
50-Day Moving Average | 11.13 |
200-Day Moving Average | 14.75 |
Relative Strength Index (RSI) | 30.99 |
Average Volume (20 Days) | 889,947 |
Short Selling Information
The latest short interest is 7.42 million, so 7.01% of the outstanding shares have been sold short.
Short Interest | 7.42M |
Short Previous Month | 6.47M |
Short % of Shares Out | 7.01% |
Short % of Float | 11.26% |
Short Ratio (days to cover) | 5.04 |
Income Statement
In the last 12 months, RCUS had revenue of $258.00 million and -$283.00 million in losses. Loss per share was -$3.14.
Revenue | 258.00M |
Gross Profit | -190.00M |
Operating Income | -310.00M |
Pretax Income | -246.00M |
Net Income | -283.00M |
EBITDA | -300.00M |
EBIT | -310.00M |
Loss Per Share | -$3.14 |
Full Income Statement Balance Sheet
The company has $978.00 million in cash and $159.00 million in debt, giving a net cash position of $833.00 million or $7.87 per share.
Cash & Cash Equivalents | 978.00M |
Total Debt | 159.00M |
Net Cash | 833.00M |
Net Cash Per Share | $7.87 |
Equity (Book Value) | 485.00M |
Book Value Per Share | 5.26 |
Working Capital | 790.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$170.00 million and capital expenditures -$6.00 million, giving a free cash flow of -$176.00 million.
Operating Cash Flow | -170.00M |
Capital Expenditures | -6.00M |
Free Cash Flow | -176.00M |
FCF Per Share | -$1.66 |
Full Cash Flow Statement Margins
Gross margin is -73.64%, with operating and profit margins of -120.16% and -109.69%.
Gross Margin | -73.64% |
Operating Margin | -120.16% |
Pretax Margin | -109.30% |
Profit Margin | -109.69% |
EBITDA Margin | -116.28% |
EBIT Margin | -120.16% |
FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.76% |
Shareholder Yield | -21.76% |
Earnings Yield | -31.50% |
FCF Yield | -19.59% |
Dividend Details Analyst Forecast
The average price target for RCUS is $29.50, which is 259.32% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $29.50 |
Price Target Difference | 259.32% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 27.99% |
EPS Growth Forecast (5Y) | -7.86% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of 0.11 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.11 |
Piotroski F-Score | 3 |